296 related articles for article (PubMed ID: 19953925)
21. High titre of antiglutamic acid decarboxylase autoantibody is a strong predictor of the development of thyroid autoimmunity in patients with type 1 diabetes and latent autoimmune diabetes in adults.
Jin P; Huang G; Lin J; Yang L; Xiang B; Zhou W; Zhou Z
Clin Endocrinol (Oxf); 2011 May; 74(5):587-92. PubMed ID: 21470281
[TBL] [Abstract][Full Text] [Related]
22. Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2.
Tiberti C; Giordano C; Locatelli M; Bosi E; Bottazzo GF; Buzzetti R; Cucinotta D; Galluzzo A; Falorni A; Dotta F
Diabetes; 2008 May; 57(5):1276-83. PubMed ID: 18332100
[TBL] [Abstract][Full Text] [Related]
23. Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.
Tripathy D; Carlsson AL; Lehto M; Isomaa B; Tuomi T; Groop L
Diabetologia; 2000 Dec; 43(12):1476-83. PubMed ID: 11151756
[TBL] [Abstract][Full Text] [Related]
24. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
Festa A; Williams K; Hanley AJ; Haffner SM
Diabetes; 2008 Jun; 57(6):1638-44. PubMed ID: 18332099
[TBL] [Abstract][Full Text] [Related]
25. Clinical and metabolic characteristics of patients with latent autoimmune diabetes in adults (LADA): absence of rapid beta-cell loss in patients with tight metabolic control.
Chaillous L; Bouhanick B; Kerlan V; Mathieu E; Lecomte P; Ducluzeau PH; Delamaire M; Sonnet E; Maugendre D; Maréchaud R; Rohmer V; Saï P; Charbonnel B
Diabetes Metab; 2010 Feb; 36(1):64-70. PubMed ID: 20060765
[TBL] [Abstract][Full Text] [Related]
26. Carboxypeptidase-H autoantibodies differentiate a more latent subset of autoimmune diabetes from phenotypic type 2 diabetes among Chinese adults.
Yang L; Zhou ZG; Tan SZ; Huang G; Jin P; Yan X; Li X; Peng H; Hagopian W
Ann N Y Acad Sci; 2008 Dec; 1150():263-6. PubMed ID: 19120309
[TBL] [Abstract][Full Text] [Related]
27. Clinical manifestation and islet β-cell function of a subtype of latent autoimmune diabetes in adults (LADA): positive for T cell responses in phenotypic type 2 diabetes.
Liang H; Cheng Y; Tang W; Cui Q; Yuan J; Huang G; Yang L; Zhou Z
Acta Diabetol; 2019 Nov; 56(11):1225-1230. PubMed ID: 31367990
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-6 and Interleukin-15 as Possible Biomarkers of the Risk of Autoimmune Diabetes Development.
Siewko K; Maciulewski R; Zielinska-Maciulewska A; Poplawska-Kita A; Szumowski P; Wawrusiewicz-Kurylonek N; Lipinska D; Milewski R; Gorska M; Kretowski A; Szelachowska M
Biomed Res Int; 2019; 2019():4734063. PubMed ID: 31772933
[TBL] [Abstract][Full Text] [Related]
29. Comparison of adults with insulin resistance (IR) in latent autoimmune diabetes versus IR in glutamic acid decarboxylase antibody-negative diabetes.
Salem SD; Saif-Ali R; Muniandy S; Al-Hamodi Z; Ismail IS
Ann Acad Med Singap; 2014 Feb; 43(2):107-12. PubMed ID: 24652431
[TBL] [Abstract][Full Text] [Related]
30. Prognostic markers for the development of type 1 diabetes in first-degree relatives of diabetic patients.
Siewko K; Popławska-Kita A; Telejko B; Maciulewski R; Zielińska A; Nikołajuk A; Górska M; Szelachowska M
Endokrynol Pol; 2014; 65(3):176-80. PubMed ID: 24971917
[TBL] [Abstract][Full Text] [Related]
31. Anti-CD38 autoantibodies: characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies.
Mallone R; Ortolan E; Pinach S; Volante M; Zanone MM; Bruno G; Baj G; Lohmann T; Cavallo-Perin P; Malavasi F
Diabetologia; 2002 Dec; 45(12):1667-77. PubMed ID: 12488956
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of latent autoimmune diabetes of adults (LADA) in Southern Spain.
Soriguer-Escofet F; Esteva I; Rojo-Martinez G; Ruiz de Adana S; Catalá M; Merelo MJ; Aguilar M; Tinahones F; García-Almeida JM; Gómez-Zumaquero JM; Cuesta-Muñoz AL; Ortego J; Freire JM;
Diabetes Res Clin Pract; 2002 Jun; 56(3):213-20. PubMed ID: 11947969
[TBL] [Abstract][Full Text] [Related]
33. Tetraspanin 7 autoantibodies predict progressive decline of beta cell function in individuals with LADA.
Shi X; Huang G; Wang Y; Liu Z; Deng C; Li X; Zheng P; Zhou Z
Diabetologia; 2019 Mar; 62(3):399-407. PubMed ID: 30594957
[TBL] [Abstract][Full Text] [Related]
34. The prevalence and characteristics of latent autoimmune diabetes in adults subset among type two diabetes mellitus patients in Northern Nigeria.
Muazu SB; Okpe I; Anumah F
Ann Afr Med; 2016; 15(4):163-170. PubMed ID: 27853030
[TBL] [Abstract][Full Text] [Related]
35. Six-year follow-up of pancreatic beta cell function in adults with latent autoimmune diabetes.
Yang L; Zhou ZG; Huang G; Ouyang LL; Li X; Yan X
World J Gastroenterol; 2005 May; 11(19):2900-5. PubMed ID: 15902725
[TBL] [Abstract][Full Text] [Related]
36. Insulin resistance, β-cell dysfunction and differences in curves of plasma glucose and insulin in the intermediate points of the standard glucose tolerance test in adults with cystic fibrosis.
Cano Megías M; González Albarrán O; Guisado Vasco P; Lamas Ferreiro A; Máiz Carro L
Endocrinol Nutr; 2015 Feb; 62(2):91-9. PubMed ID: 25444978
[TBL] [Abstract][Full Text] [Related]
37. Latent Autoimmune Diabetes in Adults (LADA) and its Metabolic Characteristics among Yemeni Type 2 Diabetes Mellitus Patients.
Al-Zubairi T; Al-Habori M; Saif-Ali R
Diabetes Metab Syndr Obes; 2021; 14():4223-4232. PubMed ID: 34675573
[TBL] [Abstract][Full Text] [Related]
38. Insulin resistance and fasting plasma glucose in first degree relatives of patients with type 1 diabetes.
Siewko K; Popławska-Kita A; Telejko B; Maciulewski R; Zielińska A; Nikołajuk A; Górska M; Szelachowska M
J Diabetes Complications; 2013; 27(6):593-6. PubMed ID: 23890682
[TBL] [Abstract][Full Text] [Related]
39. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
Tuomi T; Carlsson A; Li H; Isomaa B; Miettinen A; Nilsson A; Nissén M; Ehrnström BO; Forsén B; Snickars B; Lahti K; Forsblom C; Saloranta C; Taskinen MR; Groop LC
Diabetes; 1999 Jan; 48(1):150-7. PubMed ID: 9892237
[TBL] [Abstract][Full Text] [Related]
40. Latent Autoimmune Diabetes in Adults: Background, Safety and Feasibility of an Ongoing Pilot Study With Intra-Lymphatic Injections of GAD-Alum and Oral Vitamin D.
Björklund A; Hals IK; Grill V; Ludvigsson J
Front Endocrinol (Lausanne); 2022; 13():926021. PubMed ID: 35923626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
